These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 5083175)

  • 21. Urinary excretion of dopamine and homovanillic acid during L-dopa treatment of Parkinson's disease.
    Streifler M; Vardi Y; Kesten M; Oberman Z; Herzberg M
    Isr J Med Sci; 1972 May; 81(5):597-601. PubMed ID: 5042950
    [No Abstract]   [Full Text] [Related]  

  • 22. Biochemical investigations in patients with Parkinson's disease treated with L-dopa.
    Jequier E; Dufresne JJ
    Neurology; 1972 Jan; 22(1):15-21. PubMed ID: 5061836
    [No Abstract]   [Full Text] [Related]  

  • 23. Catecholamine metabolism in affective disorders. IV. Preliminary studies of norepinephrine metabolism in depressed patients treated with amitriptyline.
    Schildkraut JJ; Draskoczy PR; Gershon ES; Reich P; Grab EL
    J Psychiatr Res; 1972 Sep; 9(3):173-85. PubMed ID: 5083173
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of antacid administration on the absorption and metabolism of levodopa.
    Leon AS; Spiegel HE
    J Clin Pharmacol New Drugs; 1972 Jul; 12(7):263-7. PubMed ID: 4483533
    [No Abstract]   [Full Text] [Related]  

  • 25. Monoamine precursors in the treatment of depression.
    Carroll BJ
    Clin Pharmacol Ther; 1971; 12(5):743-61. PubMed ID: 4936139
    [No Abstract]   [Full Text] [Related]  

  • 26. Urinary catecholamine metabolites during behavioral changes in a patient with manic-depressive cycles.
    Jones FD; Maas JW; Dekirmenjian H; Fawcett JA
    Science; 1973 Jan; 179(4070):300-2. PubMed ID: 4683130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a screening test for L-dopa and its metabolites in urine.
    Routh JI; Bannow RE
    Clin Chem; 1971 Sep; 17(9):872-4. PubMed ID: 5571486
    [No Abstract]   [Full Text] [Related]  

  • 28. [Catecholamine metabolism in manic-depressive psychosis].
    Usherenko LS
    Fiziol Zh; 1970; 16(3):393-9. PubMed ID: 5509683
    [No Abstract]   [Full Text] [Related]  

  • 29. Excretion of L-dopa and its metabolites in urine of Parkinson's disease patients receiving L-dopa therapy.
    Routh JI; Bannow RE; Fincham RW; Stoll JL
    Clin Chem; 1971 Sep; 17(9):867-71. PubMed ID: 5571485
    [No Abstract]   [Full Text] [Related]  

  • 30. [Determination of homoprotocatechic acid in urine by a radioisotopic method].
    Comoy E; Bohuon C
    Clin Chim Acta; 1972 Jan; 36(1):207-12. PubMed ID: 5007702
    [No Abstract]   [Full Text] [Related]  

  • 31. Fluorometric method for quantitatively estimating urinary dihydroxyphenylethylamine (dopamine), dihydroxyphenylalanine (dopa), and dihydroxyphenylacetic acid (dopac).
    Eichhorn F; Rutenberg A; Kott E
    Clin Chem; 1971 Apr; 17(4):296-300. PubMed ID: 5552365
    [No Abstract]   [Full Text] [Related]  

  • 32. Excretion of dopa metabolites.
    Kott E; Bornstein B; Eichhorn F
    N Engl J Med; 1971 Feb; 284(7):395. PubMed ID: 5539935
    [No Abstract]   [Full Text] [Related]  

  • 33. Autonomic hyperreflexia and catecholamine metabolites in spinal cord injury.
    Sell GH; Naftchi NE; Lowman EW; Rusk HA
    Arch Phys Med Rehabil; 1972 Sep; 53(9):415-7. PubMed ID: 5077816
    [No Abstract]   [Full Text] [Related]  

  • 34. Dose-related alterations in metabolism of levodopa: possible mechanism for hypotensive effect.
    Kochar MS; Itskovitz HD; Sasse EA; Baker JD; Doumas BT
    J Clin Pharmacol; 1974; 14(8):448-54. PubMed ID: 4851433
    [No Abstract]   [Full Text] [Related]  

  • 35. Cyclic AMP in cerebrospinal fluid of manic and depressive patients.
    Post RM; Cramer H; Goodwin FK
    Psychol Med; 1977 Nov; 7(4):599-605. PubMed ID: 201957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Catecholamine excretion in children with neurogenic tumors of the mediastinum].
    Stepanov EA; Bukhny AE; Bol'shakova TD; Lukicheva TI
    Khirurgiia (Mosk); 1972 Jun; 48(6):125-8. PubMed ID: 5043043
    [No Abstract]   [Full Text] [Related]  

  • 37. Urinary excreion of DOPA and metabolites by patients with melanoma.
    Voorhess ML
    Cancer; 1970 Jul; 26(1):146-9. PubMed ID: 5424526
    [No Abstract]   [Full Text] [Related]  

  • 38. [Urinary excretion of 3,4-dihydroxyphenyl-alanine, 3-O-methyldopa, dopamine and homovanillic acid in man. Effects of an inhibitor of decarboxylase of aromatic amino acids (Benserazide) (author's transl)].
    Geissbühler F; Widmer J
    J Clin Chem Clin Biochem; 1976 Nov; 14(11):543-7. PubMed ID: 1003116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variation of levodopa metabolism with gastrointestinal absorption site.
    Sandler M; Ruthven CR; Goodwin BL; Hunter KR; Stern GM
    Lancet; 1974 Feb; 1(7851):238-40. PubMed ID: 4130247
    [No Abstract]   [Full Text] [Related]  

  • 40. Exploration of affective illness.
    Gershon S; Shopsin B; Wilk S
    Neuropsychobiology; 1976; 2(2-3):145-60. PubMed ID: 138099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.